Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2018

09.02.2018 | Original Article – Cancer Research

A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models

verfasst von: Ashirbani Saha, Michael R. Harowicz, Weiyao Wang, Maciej A. Mazurowski

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine whether multivariate machine learning models of algorithmically assessed magnetic resonance imaging (MRI) features from breast cancer patients are associated with Oncotype DX (ODX) test recurrence scores.

Methods

A set of 261 female patients with invasive breast cancer, pre-operative dynamic contrast enhanced magnetic resonance (DCE-MR) images and available ODX score at our institution was identified. A computer algorithm extracted a comprehensive set of 529 features from the DCE-MR images of these patients. The set of patients was divided into a training set and a test set. Using the training set we developed two machine learning-based models to discriminate (1) high ODX scores from intermediate and low ODX scores, and (2) high and intermediate ODX scores from low ODX scores. The performance of these models was evaluated on the independent test set.

Results

High against low and intermediate ODX scores were predicted by the multivariate model with AUC 0.77 (95% CI 0.56–0.98, p < 0.003). Low against intermediate and high ODX score was predicted with AUC 0.51 (95% CI 0.41–0.61, p = 0.75).

Conclusion

A moderate association between imaging and ODX score was identified. The evaluated models currently do not warrant replacement of ODX with imaging alone.
Literatur
Zurück zum Zitat (2006) NSABP study confirms oncotype DX predicts chemotherapy benefit in breast cancer patients. Oncology 20:789–790 (2006) NSABP study confirms oncotype DX predicts chemotherapy benefit in breast cancer patients. Oncology 20:789–790
Zurück zum Zitat Arasu VA, Chen RCY, Newitt DN, Chang CB, Tso H, Hylton NM, Joe BN (2011) Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol 18:716–721CrossRefPubMedPubMedCentral Arasu VA, Chen RCY, Newitt DN, Chang CB, Tso H, Hylton NM, Joe BN (2011) Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol 18:716–721CrossRefPubMedPubMedCentral
Zurück zum Zitat Ashraf AB, Daye D, Gavenonis S, Mies C, Feldman M, Rosen M, Kontos D (2014) Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Radiology 272:374–384CrossRefPubMedPubMedCentral Ashraf AB, Daye D, Gavenonis S, Mies C, Feldman M, Rosen M, Kontos D (2014) Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Radiology 272:374–384CrossRefPubMedPubMedCentral
Zurück zum Zitat Blaschke E, Abe H (2015) MRI phenotype of breast cancer: kinetic assessment for molecular subtypes. J Magn Reson Imaging 42:920–924CrossRefPubMed Blaschke E, Abe H (2015) MRI phenotype of breast cancer: kinetic assessment for molecular subtypes. J Magn Reson Imaging 42:920–924CrossRefPubMed
Zurück zum Zitat Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel M, André F (2015) Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26:1533–1546CrossRefPubMedPubMedCentral Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel M, André F (2015) Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26:1533–1546CrossRefPubMedPubMedCentral
Zurück zum Zitat Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845 Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845
Zurück zum Zitat Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier AK, Cowens JW, Ferree S, Storhoff J, Schaper C, Cuzick J (2013) Comparison of PAM50 risk of recurrence score with onco type DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol 31:2783–2790CrossRefPubMed Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier AK, Cowens JW, Ferree S, Storhoff J, Schaper C, Cuzick J (2013) Comparison of PAM50 risk of recurrence score with onco type DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol 31:2783–2790CrossRefPubMed
Zurück zum Zitat Fan M, Li H, Wang S, Zheng B, Zhang J, Li L 2017. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer. PLOS One 12:e0171683CrossRefPubMedPubMedCentral Fan M, Li H, Wang S, Zheng B, Zhang J, Li L 2017. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer. PLOS One 12:e0171683CrossRefPubMedPubMedCentral
Zurück zum Zitat Gage MM, Rosman M, Mylander WC, Giblin E, Kim H-S, Cope L, Umbricht C, Wolff AC, Tafra L (2015) A validated model for identifying patients unlikely to benefit from the 21-gene recurrence score assay. Clin Breast Cancer 15:467–472CrossRefPubMedPubMedCentral Gage MM, Rosman M, Mylander WC, Giblin E, Kim H-S, Cope L, Umbricht C, Wolff AC, Tafra L (2015) A validated model for identifying patients unlikely to benefit from the 21-gene recurrence score assay. Clin Breast Cancer 15:467–472CrossRefPubMedPubMedCentral
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
Zurück zum Zitat Harowicz MR, Robinson TJ, Dinan MA, Saha A, Marks JR, Marcom PK, Mazurowski MA (2017) Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset. Breast Cancer Res Treat 162:1–10CrossRefPubMedPubMedCentral Harowicz MR, Robinson TJ, Dinan MA, Saha A, Marks JR, Marcom PK, Mazurowski MA (2017) Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset. Breast Cancer Res Treat 162:1–10CrossRefPubMedPubMedCentral
Zurück zum Zitat Kim JJ, Kim JY, Kang HJ, Shin JK, Kang T, Lee SW, Bae YT (2017) Computer-aided diagnosis-generated kinetic features of breast cancer at preoperative MR imaging: association with disease-free survival of patients with primary operable invasive breast cancer. Radiology 284:45–54CrossRefPubMed Kim JJ, Kim JY, Kang HJ, Shin JK, Kang T, Lee SW, Bae YT (2017) Computer-aided diagnosis-generated kinetic features of breast cancer at preoperative MR imaging: association with disease-free survival of patients with primary operable invasive breast cancer. Radiology 284:45–54CrossRefPubMed
Zurück zum Zitat Klein ME, Dabbs DJ, Shuai Y, Brufsky AM, Jankowitz R, Puhalla SL, Bhargava R (2013) Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Mod Pathol 26:658CrossRefPubMedPubMedCentral Klein ME, Dabbs DJ, Shuai Y, Brufsky AM, Jankowitz R, Puhalla SL, Bhargava R (2013) Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Mod Pathol 26:658CrossRefPubMedPubMedCentral
Zurück zum Zitat Leijenaar RT, Carvalho S, Velazquez ER, Van Elmpt WJC, Parmar C, Hoekstra OS, Hoekstra CJ, Boellaard R, Dekker ALAJ, Gillies RJ, Aerts HJWL, Lambin P (2013) Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol 52(7):1391–1397CrossRefPubMed Leijenaar RT, Carvalho S, Velazquez ER, Van Elmpt WJC, Parmar C, Hoekstra OS, Hoekstra CJ, Boellaard R, Dekker ALAJ, Gillies RJ, Aerts HJWL, Lambin P (2013) Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol 52(7):1391–1397CrossRefPubMed
Zurück zum Zitat Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C, Conzen SD, Whitman GJ, Sutton EJ, Net JM, Ganott M, Huang E, Morris EA, Perou CM, Ji Y, Giger ML (2016a) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of mammaprint, oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C, Conzen SD, Whitman GJ, Sutton EJ, Net JM, Ganott M, Huang E, Morris EA, Perou CM, Ji Y, Giger ML (2016a) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of mammaprint, oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral
Zurück zum Zitat Li H, Zhu Y, Burnside ES, Huang E, Drukker K, Hoadley KA, Fan C, Conzen SD, Zuley M, Net JM, Sutton E, Whitman GJ, Morris E, Perou CM, Ji Y, Giger ML (2016b) Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer 2:16012CrossRefPubMedPubMedCentral Li H, Zhu Y, Burnside ES, Huang E, Drukker K, Hoadley KA, Fan C, Conzen SD, Zuley M, Net JM, Sutton E, Whitman GJ, Morris E, Perou CM, Ji Y, Giger ML (2016b) Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer 2:16012CrossRefPubMedPubMedCentral
Zurück zum Zitat Mazurowski MA (2015) Radiogenomics: what it is and why it is important. J Am Coll Radiol 12:862–866CrossRefPubMed Mazurowski MA (2015) Radiogenomics: what it is and why it is important. J Am Coll Radiol 12:862–866CrossRefPubMed
Zurück zum Zitat Mazurowski MA, Zhang J, Grimm LJ, Yoon SC, Silber JI (2014) Radiogenomic analysis of breast cancer: Luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology 273:365–372CrossRefPubMed Mazurowski MA, Zhang J, Grimm LJ, Yoon SC, Silber JI (2014) Radiogenomic analysis of breast cancer: Luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology 273:365–372CrossRefPubMed
Zurück zum Zitat Mazurowski MA, Grimm LJ, Zhang J, Macrom PK, Yoon S, Kim C, Ghate S, Johnson K (2015) Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms. Eur J Radiol 84(11):2117–2122 Mazurowski MA, Grimm LJ, Zhang J, Macrom PK, Yoon S, Kim C, Ghate S, Johnson K (2015) Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms. Eur J Radiol 84(11):2117–2122
Zurück zum Zitat Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J (2010) A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer. Clin Cancer Res:1078–0432 Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J (2010) A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer. Clin Cancer Res:1078–0432
Zurück zum Zitat Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A Multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826CrossRefPubMed Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A Multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826CrossRefPubMed
Zurück zum Zitat Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer. J Clin Oncol 24:3726–3734CrossRefPubMed Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer. J Clin Oncol 24:3726–3734CrossRefPubMed
Zurück zum Zitat Saha A, Grimm LJ, Harowicz M, Ghate SV, Kim C, Walsh R, Mazurowski MA (2016) Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics. Med Phys 43:4558–4564CrossRefPubMed Saha A, Grimm LJ, Harowicz M, Ghate SV, Kim C, Walsh R, Mazurowski MA (2016) Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics. Med Phys 43:4558–4564CrossRefPubMed
Zurück zum Zitat Saha A, Yu X, Sahoo D, Mazurowski MA (2017) Effects of MRI scanner parameters on breast cancer radiomics. Expert Syst Appl 87:384–391CrossRef Saha A, Yu X, Sahoo D, Mazurowski MA (2017) Effects of MRI scanner parameters on breast cancer radiomics. Expert Syst Appl 87:384–391CrossRef
Zurück zum Zitat Sutton EJ, Oh JH, Dashevsky BZ, Veeraraghavan H, Apte AP, Thakur SB, Deasy JO, Morris EA (2015) Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay. J Magn Reson Imaging 42:1398–1406CrossRefPubMedPubMedCentral Sutton EJ, Oh JH, Dashevsky BZ, Veeraraghavan H, Apte AP, Thakur SB, Deasy JO, Morris EA (2015) Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay. J Magn Reson Imaging 42:1398–1406CrossRefPubMedPubMedCentral
Zurück zum Zitat Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, Mcmahon L, Yang Q, Shayne M, Huston A, Skinner KA (2010) A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Investig 28:978–982CrossRef Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, Mcmahon L, Yang Q, Shayne M, Huston A, Skinner KA (2010) A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Investig 28:978–982CrossRef
Zurück zum Zitat Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320CrossRefPubMedPubMedCentral Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320CrossRefPubMedPubMedCentral
Zurück zum Zitat Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed
Zurück zum Zitat Wan T, Bloch BN, Plecha D, Thompson CL, Gilmore H, Jaffe C, Harris L, Madabhushi A (2016) A radio-genomics approach for identifying high risk estrogen receptor-positive breast cancers on DCE-MRI: preliminary results in predicting OncotypeDX risk scores. Sci Rep 6:21394. https://doi.org/10.1038/srep21394 Wan T, Bloch BN, Plecha D, Thompson CL, Gilmore H, Jaffe C, Harris L, Madabhushi A (2016) A radio-genomics approach for identifying high risk estrogen receptor-positive breast cancers on DCE-MRI: preliminary results in predicting OncotypeDX risk scores. Sci Rep 6:21394. https://​doi.​org/​10.​1038/​srep21394
Zurück zum Zitat Wittner BS, Sgroi DC, Ryan PD, Bruinsma TJ, Glas AM, Male A, Dahiya S, Habin K, Bernards R, Haber DA (2008) Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res 14:2988–2993CrossRefPubMedPubMedCentral Wittner BS, Sgroi DC, Ryan PD, Bruinsma TJ, Glas AM, Male A, Dahiya S, Habin K, Bernards R, Haber DA (2008) Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res 14:2988–2993CrossRefPubMedPubMedCentral
Zurück zum Zitat Wu J, Sun X, Wang J, Cui Y, Kato F, Shirato H, Ikeda DM, Li R (2017) Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation. J Magn Reson Imaging 46(4):1017–1027 Wu J, Sun X, Wang J, Cui Y, Kato F, Shirato H, Ikeda DM, Li R (2017) Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation. J Magn Reson Imaging 46(4):1017–1027
Metadaten
Titel
A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models
verfasst von
Ashirbani Saha
Michael R. Harowicz
Weiyao Wang
Maciej A. Mazurowski
Publikationsdatum
09.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2595-7

Weitere Artikel der Ausgabe 5/2018

Journal of Cancer Research and Clinical Oncology 5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.